Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Ryom

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Plos Medicine|November 8, 2017
Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational studyMark A Boyd, Amanda Mocroft, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 31, 2018
Associations between serum albumin and serious non-AIDS events among people living with HIVAndreas Ronit, Camilla I Hatleberg, Lene Ryom, et al.
AIDS (London, England)|July 12, 2013
Associations between immune depression and cardiovascular events in HIV infectionCaroline A Sabin, Lene Ryom, Stephane De Wit, et al.
AIDS (London, England)|January 8, 2013
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease eventsAntonella d'Arminio Monforte, Peter Reiss, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration RateLéna G Dietrich, Catalina Barceló, Christian W Thorball, et al.
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|October 14, 2017
Abacavir use and risk of recurrent myocardial infarctionCaroline A Sabin, Lene Ryom, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|September 11, 2019
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) StudyLene Ryom, Jens Dilling Lundgren, Peter Reiss, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Plos Medicine|November 8, 2017
Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational studyMark A Boyd, Amanda Mocroft, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
AIDS (London, England)|May 31, 2018
Associations between serum albumin and serious non-AIDS events among people living with HIVAndreas Ronit, Camilla I Hatleberg, Lene Ryom, et al.
AIDS (London, England)|July 12, 2013
Associations between immune depression and cardiovascular events in HIV infectionCaroline A Sabin, Lene Ryom, Stephane De Wit, et al.
AIDS (London, England)|January 8, 2013
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease eventsAntonella d'Arminio Monforte, Peter Reiss, Lene Ryom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2019
Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration RateLéna G Dietrich, Catalina Barceló, Christian W Thorball, et al.
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|October 14, 2017
Abacavir use and risk of recurrent myocardial infarctionCaroline A Sabin, Lene Ryom, Antonella d'Arminio Monforte, et al.
The Journal of Infectious Diseases|September 11, 2019
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) StudyLene Ryom, Jens Dilling Lundgren, Peter Reiss, et al.
Pageof 11